Diabetic Macular Edema

March 2008
PN;Mar2008, Vol. 62 Issue 3, p48
Trade Publication
The article focuses on the possible association of a newly diagnosed vision problems and diabetes. It is noted that a diabetic macular edema may be the cause of blurry vision, which could be an early sign of diabetic retinopathy. It appears when the swelling of the retina occurs due to leaking of fluid from blood vessels within the macula. This condition is closely associated with the degree of diabetic retinopathy. It is also common in people with who have diabetes.


Related Articles

  • High Cardiovascular Disease Mortality in Subjects With Visual Impairment Caused by Diabetic Retinopathy. Rajala, Ulla; Pajunpaa, Hannu; Koskela, Pentti; Keinanen-Kiukaanniemi, Sirkka // Diabetes Care;Jul2000, Vol. 23 Issue 7, p957 

    Focuses on a study which assessed the mortality and causes of death in subjects with visual impairment caused by diabetic retinopathy. Account of related studies; Research design and methods; Conclusions.

  • NEW WAYS OF LOOKING AT RETINAL DISEASE. Dinsmoor, Robert S. // Countdown;Summer2006, Vol. 27 Issue 3, p8 

    The article focuses on diabetic retinopathy, a disease of the retina of the eye connected to diabetes. It is a major causation of blindness in Americans, who are 65 years or older. The two major complications of diabetic retinopathy are diabetic macular edema and proliferative diabetic...

  • PKC-β inhibitor may reduce risk of vision loss in DME. Groves, Nancy // Ophthalmology Times;4/1/2005, Vol. 30 Issue 7, p52 

    Announces the results of the evaluation of the chemical inhibitor, ruboxistaurin which may reduce the risk of vision loss associated with diabetic macular edema (DME). Proximity of DME to the center of the macula which was associated with visual acuity and the severity of central macular...

  • Are Individuals With Diabetes Seeing Better? Klein, Ronald; Klein, Barbara E. K. // Diabetes;Aug2010, Vol. 59 Issue 8, p1853 

    The article examines the link between changes in the management of diabetes, its retinal and visual complications and changes in diabetic retinopathy (DR) and visual impairment (VI) incidence and progression based on research since 1980. The efficacy of blood pressure control in reducing DR...

  • A Comparison of Quantitative Mapping and Stereoscopic Fundus Photography Grading of Retinal Thickness in Diabetic Eyes With Macular Edema. Yunsik Yang; Vitale, Susan; Ding, Yulan; O'Connell, Stephen R.; Alexander, Judith; Bressler, Neil M.; Schachat, Andrew P.; Zeimer, Ran // Ophthalmic Surgery, Lasers & Imaging;Jan/Feb2003, Vol. 34 Issue 1, p7 

    OBJECTIVE: To evaluate the ability of a retina specialist's grading of 30° color stereoscopic fundus photographs to identify areas of significant retinal thickening as assessed by the Retinal Thickness Analyzer (RTA) and to determine whether this ability was affected by the presence of...

  • Diabetic retinopathy: the current status of therapy. Nemchik, Rita // RN;Jun83, Vol. 46 Issue 6, p34 

    Provides information on diabetic retinopathy. Information on the kinds and stages of retinopathy; Diagnosis and treatment; Guidelines for prevention of visual impairment. INSET: RESOURCES FOR THE DIABETIC WITH VISUAL IMPAIRMENT.

  • Photocoagulation in the prevention of blindness due to diabetic retinopathy: a review. Kohner, E. M. // Journal of the Royal Society of Medicine;Mar1984, Vol. 77 Issue 3, p227 

    The article discusses the surgical procedure in the prevention of blindness due to diabetic retinopathy. The causes of visual loss in diabetic retinopathy include proliferative retinopathy and diabetic maculopathy. Surgical procedure for diabetic retinopathy is the application of light energy to...

  • Sustained moderate visual loss as a predictive end point for visual loss in non-proliferative diabetic retinopathy. Girach, A.; Aiello, L. P.; Milton, R. C.; Davis, M. D.; Danis, R. P.; Zhi, X.; Sheetz, M. J.; Vignati, L. // Eye;Jan2009, Vol. 23 Issue 1, p209 

    PurposeIn PKC-DRS2, the efficacy of the oral PKC-β inhibitor, ruboxistaurin 32 mg/day, was measured by the primary end point of sustained moderate visual loss (SMVL: a 15 letter decrease from baseline on the ETDRS (Early Treatment Diabetic Retinopathy Study) chart sustained at least...

  • Characterisation of the vitreous proteome in proliferative diabetic retinopathy.  // Proteome Science;2012, Vol. 10 Issue 1, p15 

    The article reports that diabetes is a disease which can lead to serious microvascular complications. It states that these complications can lead to proliferative diabetic retinopathy (PDR), which results in severe vision loss. It aims at comparing the protein profile of vitreous humour from...

  • Retinopathy. Watkins, Peter J. // BMJ: British Medical Journal (International Edition);4/26/2003, Vol. 326 Issue 7395, p924 

    Provides observations about diabetic retinopathy or blindness. How diabetic retinopathy is due to microangiopathy affecting the retinal precapillary arterioles, capillaries, and venules; Damage from microvasucal leakage from breakdown of the inner blood-retinal barrier and microvascular...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics